title: Antagonism of host antiviral responses by Kaposi's sarcoma-associated herpesvirus tegument protein ORF45.
abstract: Virus infection of a cell generally evokes an immune response by the host to defeat the intruder in its effort. Many viruses have developed an array of strategies to evade or antagonize host antiviral responses. Kaposi's sarcoma-associated herpesvirus (KSHV) is demonstrated in this report to be able to prevent activation of host antiviral defense mechanisms upon infection. Cells infected with wild-type KSHV were permissive for superinfection with vesicular stomatitis virus (VSV), suggesting that KSHV virions fail to induce host antiviral responses. We previously showed that ORF45, a KSHV immediate-early protein as well as a tegument protein of virions, interacts with IRF-7 and inhibits virus-mediated type I interferon induction by blocking IRF-7 phosphorylation and nuclear translocation (Zhu et al., Proc. Natl. Acad. Sci. USA. 99:5573-5578, 2002). Here, using an ORF45-null recombinant virus, we demonstrate a profound role of ORF45 in inhibiting host antiviral responses. Infection of cells with an ORF45-null mutant recombinant KSHV (BAC-stop45) triggered an immune response that resisted VSV super-infection, concomitantly associated with appreciable increases in transcription of type I IFN and downstream anti-viral effector genes. Gain-of-function analysis showed that ectopic expression of ORF45 in human fibroblast cells by a lentivirus vector decreased the antiviral responses of the cells. shRNA-mediated silencing of IRF-7, that predominantly regulates both the early and late phase induction of type I IFNs, clearly indicated its critical contribution to the innate antiviral responses generated against incoming KSHV particles. Thus ORF45 through its targeting of the crucial IRF-7 regulated type I IFN antiviral responses significantly contributes to the KSHV survival immediately following a primary infection allowing for progression onto subsequent stages in its life-cycle.
authors.affiliation: Department of Biological Science, Florida State University, Tallahassee, Florida, United States of America.
authors.forename: Fan Xiu
authors.initials: FX
authors.lastname: Zhu
authors.forename: Narayanan
authors.initials: N
authors.lastname: Sathish
authors.forename: Yan
authors.initials: Y
authors.lastname: Yuan
mesh_terms: D005347:Fibroblasts / Q000378:metabolism / Q000821:virology; D005822:Genetic Vectors / Q000235:genetics; D019288:Herpesvirus 8, Human / Q000276:immunology; D054884:Host-Pathogen Interactions / Q000276:immunology*; D006801:Humans; D017874:Immediate-Early Proteins / Q000276:immunology*; D007113:Immunity, Innate / Q000276:immunology; D050839:Interferon Regulatory Factor-7 / Q000235:genetics; D007370:Interferon Type I / Q000276:immunology; D016086:Lentivirus / Q000235:genetics; D011995:Recombination, Genetic / Q000235:genetics; D012514:Sarcoma, Kaposi / Q000276:immunology / Q000821:virology; D015398:Signal Transduction / Q000276:immunology; D012995:Solubility; D014158:Transcription, Genetic; D014771:Virion / Q000276:immunology
chemical_list: C494234:IRF7 protein, human; D017874:Immediate-Early Proteins; D050839:Interferon Regulatory Factor-7; D007370:Interferon Type I; C456286:ORF45 protein, Kaposi's sarcoma-associated herpesvirus